NCT00748995

Brief Summary

This is a research study examining health effects of the Iraq War, especially those effects involving mental health. This study is a follow-up to the Neurocognition Deployment Health Study (NDHS), also called "Prospective Assessment of Neurocognition in Future Gulf-deployed and Gulf-nondeployed Military Personnel: A Pilot Study." The specific purpose of this research study is to find out more about the longer lasting effects of war on mood and stress symptoms, thinking and reaction skills, and different aspects of day to day life, such as work and daily activities. Survey and test results from previous participation in the NDHS will be compared to the new information that will be obtained from participants as part of this study. The investigators expect that a total of about 817 military personnel and military Veterans will participate in the study. There are two parts to this study: (1) mail/internet/phone survey and (2) in-person assessment. The investigators will invite all NDHS participants who deployed to Iraq to participate in the survey component. The survey component of the study involves being interviewed by phone about mood and stress symptoms and head injuries and completing written survey questions by either mail or on the internet that address basic personal history (such as age, military status, gender, combat injury history), mood, stress symptoms, and stressful experiences. The phone interview will take about 2 to 2.5 hours to complete. The questionnaire part will take about 20 to 30 minutes to complete, and can be completed either by mailing back completed questionnaires or by internet using a private, individual log-in/password combination. The investigators will invite approximately 200 selected at random from the larger group of survey responders to take part in the in-person assessment. The in-person assessment involves taking a small subset of neuropsychological tasks. The tasks will be given on a computer or using paper and pencil. Participants will also be asked to complete questionnaires about work, daily activities, and health history, as well as basic health measures such as height, weight, blood pressure, heart rate, and waist size. Potential participants will be given the option of completing the in-person assessment at one of the two study sites (Seattle or Boston), or in a private setting in their community (e.g., a hotel small conference room). Altogether, this part of the study will take about 120 minutes to 140 minutes to complete.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
817

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started Aug 2010

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Aug 2010Sep 2027

First Submitted

Initial submission to the registry

September 5, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 9, 2008

Completed
2 years until next milestone

Study Start

First participant enrolled

August 31, 2010

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2014

Completed
13.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Expected
Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

3.9 years

First QC Date

September 5, 2008

Last Update Submit

September 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Post-traumatic stress disorder (PTSD) diagnosis (current CAPS dx); PTSD threshold (PCL derived screening estimate)

    1. PTSD dx (current CAPS dx at T3) 2. PTSD threshold dx (PCL-derived screening estimate) for T3 vs. T1 comparison 3. Trajectory patterns of PTSD threshold dx\* (PCL-derived screening estimate) at T1, T2, and/or T3: * never (T1-,T2-,T3-) * persistent (T1-,T2+,T3+) * recovered (T1-,T2+,T3-) * late onset (T1-,T2-,T3+) * all others, e.g., pre- existing (T1+,T2+,T3+) \[\* +/- regarding PTSD threshold at time T1,2,3\]

    5 years

  • Neuropsych performance

    * Neuropsych performance (T1 v. T2 v. T3) * Post-traumatic stress disorder (PTSD) diagnosis (CAPS dx); PTS symptom severity (PCL summary scores) (T3)

    5 years

Secondary Outcomes (2)

  • Association of early/deploy/post-deploy stress exposures and PTSD, MDD, panic

    5 years

  • Association from pre-deploy to long-term follow-up (T3)

    5 years

Study Arms (1)

Neurocognition Deployment Health Study (NDHS) participants

Surviving NDHS participants who returned from their initial deployment to Iraq or Afghanistan.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surviving members of the Neurocognition Deployment Health Study (NDHS) cohort of 1595 participants

You may qualify if:

  • Deployment to Iraq with completed Neurocognition Deployment Health Study (NDHS) baseline assessments

You may not qualify if:

  • non-deployed
  • sensory-motor or cognitive loss sufficiently profound to permit meaningful participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

CERC (VISN1, West Haven, CT)

West Haven, Connecticut, 06516, United States

Location

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Boston, Massachusetts, 02130-4817, United States

Location

VA Medical Center, Jamaica Plain Campus

Boston, Massachusetts, 02130, United States

Location

VA Puget Sound Health Care System, Seattle

Seattle, Washington, 98108, United States

Location

Related Publications (9)

  • Vasterling JJ, Aslan M, Proctor SP, Ko J, Marx BP, Jakupcak M, Schnurr PP, Gleason T, Huang GD, Concato J. Longitudinal Examination of Posttraumatic Stress Disorder as a Long-Term Outcome of Iraq War Deployment. Am J Epidemiol. 2016 Dec 1;184(11):796-805. doi: 10.1093/aje/kww151. Epub 2016 Nov 16.

  • Alosco ML, Aslan M, Du M, Ko J, Grande L, Proctor SP, Concato J, Vasterling JJ. Consistency of Recall for Deployment-Related Traumatic Brain Injury. J Head Trauma Rehabil. 2016 Sep-Oct;31(5):360-8. doi: 10.1097/HTR.0000000000000201.

  • Vasterling JJ, Aslan M, Lee LO, Proctor SP, Ko J, Jacob S, Concato J. Longitudinal Associations among Posttraumatic Stress Disorder Symptoms, Traumatic Brain Injury, and Neurocognitive Functioning in Army Soldiers Deployed to the Iraq War. J Int Neuropsychol Soc. 2018 Apr;24(4):311-323. doi: 10.1017/S1355617717001059. Epub 2017 Dec 4.

  • Aslan M, Concato J, Peduzzi PN, Proctor SP, Schnurr PP, Marx BP, McFall M, Gleason T, Huang GD, Vasterling JJ. Design of "neuropsychological and mental health outcomes of operation Iraqi freedom: a longitudinal cohort study". J Investig Med. 2013 Mar;61(3):569-77. doi: 10.2310/JIM.0b013e31828407ff.

  • Vasterling JJ, Proctor SP, Aslan M, Ko J, Jakupcak M, Harte CB, Marx BP, Concato J. Military, demographic, and psychosocial predictors of military retention in enlisted army soldiers 12 months after deployment to Iraq. Mil Med. 2015 May;180(5):524-32. doi: 10.7205/MILMED-D-14-00468.

  • Vasterling JJ, Aslan M, Proctor SP, Ko J, Leviyah X, Concato J. Long-term negative emotional outcomes of warzone TBI. Clin Neuropsychol. 2020 Aug;34(6):1088-1104. doi: 10.1080/13854046.2020.1749935. Epub 2020 Apr 17.

  • Jackson CE, Ciarleglio MM, Aslan M, Marx BP, Ko J, Concato J, Proctor SP, Vasterling JJ. Associations Among Increases in Posttraumatic Stress Symptoms, Neurocognitive Performance, and Long-Term Functional Outcomes in U.S. Iraq War Veterans. J Trauma Stress. 2021 Jun;34(3):628-640. doi: 10.1002/jts.22663. Epub 2021 Mar 2.

  • Vasterling JJ, Franz MR, Lee LO, Kaiser AP, Proctor SP, Marx BP, Schnurr PP, Ko J, Concato J, Aslan M. Early predictors of chronic posttraumatic stress disorder symptom trajectories in U.S. Army soldiers deployed to the Iraq war zone. J Trauma Stress. 2023 Oct;36(5):955-967. doi: 10.1002/jts.22964. Epub 2023 Aug 22.

  • Bottari SA, Pless Kaiser A, Lee LO, Aslan M, Vasterling JJ. Pre-deployment sleep duration predicts longitudinal posttraumatic stress disorder symptom trajectories in US Army soldiers deployed to the Iraq war zone. J Anxiety Disord. 2026 Aug;122:103198. doi: 10.1016/j.janxdis.2026.103198. Epub 2026 Jun 3.

Related Links

Biospecimen

Retention: NONE RETAINED

No Biospecimens were collected

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Jennifer J Vasterling, PhD

    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2008

First Posted

September 9, 2008

Study Start

August 31, 2010

Primary Completion

July 10, 2014

Study Completion (Estimated)

September 30, 2027

Last Updated

September 14, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations